- Home
- RRGB vs ADAG Comparison
RRGB vs ADAG Comparison
Compare RRGB & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRGB
- ADAG
- Stock Information
- Founded
- RRGB 1969
- ADAG 2011
- Country
- RRGB United States
- ADAG China
- Employees
- RRGB N/A
- ADAG N/A
- Industry
- RRGB Restaurants
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- RRGB Consumer Discretionary
- ADAG Health Care
- Exchange
- RRGB Nasdaq
- ADAG Nasdaq
- Market Cap
- RRGB 88.7M
- ADAG 91.4M
- IPO Year
- RRGB 2002
- ADAG 2021
- Fundamental
- Price
- RRGB $6.01
- ADAG $1.92
- Analyst Decision
- RRGB Strong Buy
- ADAG Strong Buy
- Analyst Count
- RRGB 4
- ADAG 1
- Target Price
- RRGB $11.88
- ADAG $8.00
- AVG Volume (30 Days)
- RRGB 374.7K
- ADAG 51.2K
- Earning Date
- RRGB 08-21-2025
- ADAG 07-24-2025
- Dividend Yield
- RRGB N/A
- ADAG N/A
- EPS Growth
- RRGB N/A
- ADAG N/A
- EPS
- RRGB N/A
- ADAG N/A
- Revenue
- RRGB $1,252,370,000.00
- ADAG $103,204.00
- Revenue This Year
- RRGB N/A
- ADAG $6,488.89
- Revenue Next Year
- RRGB N/A
- ADAG $57.50
- P/E Ratio
- RRGB N/A
- ADAG N/A
- Revenue Growth
- RRGB N/A
- ADAG N/A
- 52 Week Low
- RRGB $2.50
- ADAG $1.33
- 52 Week High
- RRGB $7.05
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- RRGB 56.69
- ADAG 56.78
- Support Level
- RRGB $5.88
- ADAG $1.74
- Resistance Level
- RRGB $6.89
- ADAG $1.98
- Average True Range (ATR)
- RRGB 0.42
- ADAG 0.12
- MACD
- RRGB -0.05
- ADAG -0.00
- Stochastic Oscillator
- RRGB 61.14
- ADAG 72.22
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.